CLINICAL_TRIALS
trial_result
· 2021-01-28
Clinical Trial Update: Lorcaserin for Cannabis Use Disorder [EARLY_Phase 1]
Summary
Early-phase clinical trial of lorcaserin for cannabis use disorder has been terminated; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Cannabis Use Disorder | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2021-01-28